Mark W Geraci Selected Research

Mark W Geraci Research Topics

Disease

14	Lung Neoplasms (Lung Cancer) 10/2019 - 02/2002
12	Neoplasms (Cancer) 01/2018 - 01/2002
8	Carcinogenesis 01/2018 - 02/2002
7	Pulmonary Arterial Hypertension 01/2023 - 12/2005
6	Pulmonary Hypertension 10/2019 - 05/2002
5	Inflammation (Inflammations) 10/2019 - 12/2004
4	Adenocarcinoma 01/2018 - 08/2004
4	Infections 12/2008 - 09/2003
4	Lung Diseases (Lung Disease) 11/2008 - 05/2002
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2008 - 02/2005
4	Emphysema 04/2007 - 05/2002
3	COVID-19 01/2023 - 01/2023
3	Hypoxia (Hypoxemia) 10/2019 - 05/2002
3	Pneumonia (Pneumonitis) 11/2008 - 12/2004
2	Chronic Obstructive Pulmonary Disease (COPD) 11/2023 - 04/2007
2	Vascular Diseases (Vascular Disease) 01/2022 - 01/2021
2	Adenocarcinoma of Lung 11/2021 - 01/2008
2	Familial Primary Pulmonary Hypertension 01/2016 - 05/2002
2	Virus Diseases (Viral Diseases) 01/2016 - 09/2003
2	Sepsis (Septicemia) 08/2012 - 12/2004
2	Neoplasm Metastasis (Metastasis) 03/2009 - 02/2005
2	Vascular Remodeling 05/2003 - 05/2002
1	Hemorrhage 01/2023
1	Venous Thromboembolism 01/2023
1	Critical Illness (Critically Ill) 01/2023
1	Acidosis 10/2019
1	Primary Graft Dysfunction 10/2019
1	Reperfusion Injury 10/2019
1	Tuberculosis (Tuberculoses) 02/2016
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2016
1	Genomic Instability 02/2014
1	Respiratory Insufficiency (Respiratory Failure) 08/2012
1	Endotoxemia 08/2012
1	Systemic Scleroderma (Systemic Sclerosis) 05/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2011
1	Disease Progression 01/2010

Drug/Important Bio-Agent (IBA)

9	prostacyclin synthetase (prostacyclin synthase)IBA 01/2018 - 02/2002
9	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2018 - 05/2004
5	EicosanoidsIBA 01/2018 - 02/2002
5	PPAR gammaIBA 01/2018 - 11/2002
5	Proteins (Proteins, Gene)FDA Link 12/2008 - 05/2002
5	CarcinogensIBA 10/2008 - 02/2002
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2010
4	CytokinesIBA 10/2019 - 08/2004
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2007 - 02/2002
3	EnzymesIBA 01/2016 - 01/2005
3	Iloprost (Ventavis)FDA Link 06/2011 - 10/2008
3	SmokeIBA 10/2008 - 08/2004
3	Urethane (Ethyl Carbamate)IBA 01/2008 - 01/2005
3	Dinoprostone (PGE2)FDA Link 03/2007 - 01/2005
3	ProstaglandinsIBA 07/2006 - 08/2004
2	MicroRNAs (MicroRNA)IBA 11/2023 - 11/2006
2	RNA (Ribonucleic Acid)IBA 11/2023 - 11/2008
2	Phosphotransferases (Kinase)IBA 06/2009 - 05/2002
2	Phospholipases (Phospholipase)IBA 03/2009 - 11/2002
2	Peptide Hydrolases (Proteases)FDA Link 01/2008 - 12/2004
2	Messenger RNA (mRNA)IBA 01/2008 - 05/2002
2	Arachidonic Acid (Vitamin F)IBA 03/2007 - 01/2005
2	Prostaglandin-E SynthasesIBA 03/2007 - 01/2005
2	Butylated Hydroxytoluene (BHT)IBA 06/2006 - 01/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2004 - 05/2002
1	Protein Isoforms (Isoforms)IBA 11/2023
1	apixabanIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	von Willebrand FactorIBA 01/2023
1	P-SelectinIBA 01/2023
1	crizanlizumabIBA 01/2023
1	ThiazolidinedionesIBA 10/2019
1	Collagen Type V (Type V Collagen)IBA 10/2019
1	Semaxinib (SU5416)IBA 10/2019
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 10/2019
1	Prostaglandins DIBA 10/2019
1	Pioglitazone (Actos)FDA Link 10/2019
1	Acetazolamide (Diamox)FDA LinkGeneric 10/2019
1	Ammonium Chloride (Sal Ammoniac)FDA Link 10/2019
1	AntioxidantsIBA 01/2016
1	Superoxide DismutaseIBA 01/2016
1	InterferonsIBA 01/2016
1	Interferon Type IIBA 01/2016
1	Histones (Histone)IBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012
1	Heparitin Sulfate (Heparan Sulfate)IBA 08/2012
1	heparanaseIBA 08/2012
1	Oxidants (Oxidizing Agents)IBA 07/2012
1	ChromatinIBA 07/2012
1	8-hydroxyguanineIBA 07/2012
1	N 30IBA 05/2011
1	Growth Differentiation Factor 15IBA 05/2011
1	Interleukin-7 (Interleukin 7)IBA 10/2010
1	Chemokine ReceptorsIBA 10/2010

Therapy/Procedure

4	Therapeutics 01/2023 - 08/2006
4	Chemoprevention 10/2019 - 03/2007
2	Aftercare (After-Treatment) 10/2019 - 01/2005
2	Drug Therapy (Chemotherapy) 05/2002 - 01/2002
1	Contraindications 01/2023
1	Critical Care (Surgical Intensive Care) 01/2023
1	Precision Medicine 01/2022
1	Lasers (Laser) 11/2021
1	Lung Transplantation 10/2019
1	Immunomodulation 01/2016